<DOC>
	<DOCNO>NCT01811797</DOCNO>
	<brief_summary>This prospective , randomize , double-blind clinical study compare safety efficacy treatment perform Low Intensity Extracorporeal Shockwave Therapy ( LI-ESWT ) device - `` Renova '' symptomatic ED patient safety efficacy control sham patient .</brief_summary>
	<brief_title>Safety Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves Renova</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Good general health Vascular ED least 6 month International Index Erectile Function 6 ( IIEFEF ) 11 25 Positive response PDE5I ( able penetrate demand=Responders ) Negative response PDE5I ( unable penetrate demand even maximum PDE5I dosage = Nonresponders ) Stable heterosexual relationship 3 month Hormonal , neurological psychological pathology Past radical prostatectomy extensive pelvic surgery Recovering cancer last 5 year Any unstable medical , psychiatric , spinal cord injury penile anatomical abnormality Clinically significant chronic hematological disease Antiandrogens , oral injectable androgen Past radiotherapy treatment pelvic region International normalize ratio ( INR ) &gt; 3 patient use blood thinner ( Coumadin )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Extracorporeal shockwave</keyword>
	<keyword>Low intensity shockwaves</keyword>
</DOC>